NCT07429383Not yet recruiting
Validity and Reliability of the Hypertonia Assessment Tool (HAT) in Stroke Patients
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
In this study, the validity and reliability of the Hypertonia Assessment Tool (HAT), which has previously been validated in the pediatric cerebral palsy (CP) population, will be evaluated in adult individuals who have experienced a stroke. The HAT is a specific clinical instrument designed to differentiate subtypes of hypertonia, including spasticity, dystonia, and rigidity. Accurate classification of hypertonia subtypes following stroke is crucial for guiding rehabilitation strategies. However, the HAT has not yet been validated in the adult post-stroke population. This study will be conducted at the Physical Medicine and Rehabilitation Clinic of SBU Fatih Sultan Mehmet Training and Research Hospital. The study aims to evaluate the validity and reliability of the HAT for use in adults with stroke.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 17 Feb 2026
- Start date
- 1 Mar 2026
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- Fatih Sultan Mehmet Training and Research Hospital
- Diseases
- Stroke
- NCT number
- NCT07429383
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Mar 2026 to the primary completion date, 1 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of severe accompanying neurodegenerative diseases (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis)
- Presence of primary musculoskeletal disorders affecting motor performance (e.g., rheumatologic diseases, fractures)
- Any psychiatric disorder that may interfere with study participation
Age
- Age under 18 years
Other
- Brunnstrom stage of 1
- Severe aphasia, impaired consciousness, or cognitive deficits preventing effective communication and cooperation
Who the study is looking for
- Age 18 years and older
- Clinically and radiologically confirmed diagnosis of stroke (ischemic or -hemorrhagic)
- Brunnstrom stage between 2 and 6
- Presence of post-stroke hypertonia (spasticity, dystonia, or rigidity)
- Cognitive level sufficient to cooperate with assessments (Mini-Mental State Examination (MMSE) score \>23 or equivalent clinical evaluation)
- Provision of written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fatih Sultan Mehmet Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.